Why is the Whispir (ASX:WSP) share price rocketing 14% higher?

It has been a good day for Whispir shares…

| More on:
A boy looks up and points his fingers to the sky in celebration pose.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Whispir Ltd (ASX: WSP) share price has been a very strong performer on Wednesday.

In morning trade, the cloud-based communications management systems platform provider's shares are up 14% to $2.40.

Why is the Whispir share price rocketing higher?

Investors have been bidding the Whispir share price higher today following the release of an update on its guidance for FY 2022 ahead of its annual general meeting.

According to the release, Whispir now expects its revenue to be in the range of $64 million to $68 million in FY 2022. This represents a year on year increase of between 34% and 42%.

In addition, it is an improvement on its prior guidance of revenue in the range of $57.2 million to $60.2 million which was given just over a month ago.

But the good news doesn't stop there. Whispir's guidance for earnings before interest, tax, depreciation and amortisation (EBITDA) excluding non-cash share-based payments for FY 2022 is now a loss of $11.2 million to $13.2 million. This compares to previous guidance for a loss of $13 million to $15.5 million.

What is driving this?

Management advised that Whispir is well-positioned for growth in FY 2022, predicated by its book of long-term, blue chip clients.

It notes that several new business wins, including a sizeable customer in North America, provides confidence that the sales pipeline is strong, and the product is delivering to meet the changing needs of customers across the core regions of ANZ, Asia, and North America.

Commenting on the upgraded revenue and EBITDA guidance, Whispir founder and CEO, Jeromy Wells said:

This improved forecast performance, in revenue and EBITDA, validates that our strategy is working. Our updated guidance also highlights the valuable role we're playing in the delivery of COVID specific communications across our install base.

Our 'return to work' and 'vaccine roll-out' campaigns are clearly benefiting our top-line and they also provide an increased opportunity, for up-sell and cross-sell, introducing our platform, and our products, to an expanding customer base.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Whispir Ltd. The Motley Fool Australia has recommended Whispir Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Two fashionable asx investors dancing among confetti.
Retail Shares

Why is the Myer share price rocketing 10% on Thursday?

ASX investors are piling into Myer shares today. But why?

Read more »

3 children standing on podiums wearing Olympic medals
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rather woeful Wednesday session for the ASX today.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why 4DMedical, Megaport, Meteoric Resources, and Ramelius shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »